Mednet Logo

What would be your choice of adjuvant chemotherapy for a healthy patient with localized triple negative breast cancer who is not a candidate for anthracycline and has severe neuropathy?

Patient received anthracycline and paclitaxel for HR+ breast cancer in the past.
2 Answers
Mednet Member
Mednet MemberInvited Expert
Medical Oncology · Louisiana State University
Answered on

I probably would offer adjuvant chemotherapy with CMF. This is a regimen we don't use anymore, but it clearly improves outcome compared to no chemotherapy.

CMF as adjuvant chemotherapy in triple negative BC

This case is described as not being a candidate for anthracyclines and with severe neuropathy, ...

Join for free or sign in to see the full answer

Mednet Member
Mednet MemberInvited Expert
Medical Oncology · Icahn School of Medicine at Mount Sinai
Answered on

I'm assuming that this patient had adjuvant treatment with an anthracycline and paclitaxel for her primary treatment, and she developed a local invasive recurrence. I too would go with CMF.

Join for free or sign in to see the full answer